National Fosamax Side Effect Lawyers Report on Study Confirming Increased Risk … - YAHOO!

Parker Waichman LLP, a national law firm dedicated to protecting the legal rights of people injured by defective drugs, is warning users of Fosamax (alendronate) and other bisphosphonates of a new study linking long-term use of such drugs with an increased ...

Alonso Krangle LLP Alerts Fosamax Users to New Study Linking Long-Term Use of … - YAHOO!

Alonso Krangle LLP, a national law firm focused on fighting for the rights of serious personal injury victims of harmful drugs, are alerting Fosamax users to a new study confirming the association between atypical femur fractures and long-term use of ...

Bernstein Liebhard LLP Reports On New Study Finding Risk of Fosamax Thigh Fractures - PRWeb

Bernstein Liebhard LLP reports on a new study that found an increased risk of atypical femur fractures in people who take Fosamax. Bernstein Liebhard LLP, a nationwide law firm representing clients who experienced Fosamax thigh fractures and other side ...

Merck Barred From Contacting Plaintiff Doctors in Fosamax Fracture Suits - AboutLawsuits.com

Citing physician-patient privilege, a federal judge has barred Merck from directly contacting the doctors of patients who have filed a lawsuit after suffering bone fractures allegedly caused by the osteoporosis drug Fosamax.  In a court order (PDF) issued ...

FDA Report Cautioning Long-Term Use of Fosamax and Other Bisphosphonate Drugs Acknowledged by Rottenstein Law Group - 24-7PressRelease.com

The Rottenstein Law Group has learned of a new FDA report cautioning against the long-term use of Fosamax and other bisphosphonate drugs for the treatment of osteoporosis. NEW YORK, NY, May 16, 2012 /24-7PressRelease/-- The Rottenstein Law Group, which ...

New Cautions About Long-Term Use of Bone Drugs - New York Times Blogs

A study of Fosamax, which is sold generically as alendronate, continued for 10 years, and a study of Reclast, an injectable form of the drug zoledronic acid, continued for six years. According to the F.D.A. analysis, both studies showed ...

FDA Bisphosphonate Study Finds Few Benefits from Long-Term Use - Newsinferno.com

A new U.S. Food & Drug Administration (FDA) analysis is raising serious concerns about the long-term use of bisphosphonates like Fosamax to treat weak bones. While the bisphosphonate analysis found little if any benefit from taking the drugs for ...

The risk of ONJ with Fosamax - Seahawk

The brand name Fosamax, a drug manufactured by Merck has been recently reported to possibly cause osteonecrosis of the jaw after prolonged use. The meaning of osteonecrosis is bone death. It originates from the Latin word”osteo” which means ...

FDA’s Stance on Bisphosphonate Drugs - WebMD

The FDA is weighing in on how long is long enough to take bisphosphonates – a widely used class of osteoporosis drugs that includes Actonel, Atelvia, Boniva, and Fosamax. The short answer: It depends, but 5 years may be the key time frame. After that ...

Why Were Risky, Ineffectual Bone Drugs Approved, Some Are Asking - Food Consumer

Like Vioxx, Merck's expensive "super aspirin" that caused thousands of cardiovascular events before being recalled, Merck's Fosamax, the first bisphosphonate bone drug, flew out of the FDA with only a six-month review. And like Vioxx, the true dangers of ...